Forecast: Type 1 Diabetes.
By Rajan Sharma, Senior Analyst
18 December 2015
I joined Datamonitor Healthcare in late in 2013 after completing a Masters in Pharmacology from the University of Oxford...
Read full bio
The biggest player in the type 1 diabetes market, Lantus, is set to lose significant market share over the next ten years. With this in mind, it is crucial that you know how the market will change and how this change could affect you and your business.
Our latest type 1 diabetes 10 year forecast will enable you to:
> Delve into the type 1 diabetes market, enabling you to get a granular view of the impact that key events will have on specific brands.
> Stay ahead of your competitors by understanding how market dynamics will change, so you can effectively adapt your strategy.
> Understand the drivers and resistors of market growth in order to take advantage of opportunities in this market.
Explore our type 1 diabetes forecast by downloading your exclusive extract from this market leading report >>
Key questions answered in this report:
- Who will be the winners and losers in the diabetes type 1 market over the forecast period?
- How will the launch of insulin glargine biosimilars impact Lantus’s market share?
- What effect will the approval of the oral SGLT-2 inhibitor class for type 1 diabetes have on market dynamics?
- Which key events will drive fragmentation of the type 1 diabetes market?